CLINICAL_TRIALS
trial_result
· 2020-12-11
Clinical Trial Update: Twenty-Four Month Extension Study of BA058-05-003 (Abaloparatide) in Participants With Osteoporosis [Phase 3]
Summary
Phase 3 extension study update for abaloparatide in postmenopausal osteoporosis, completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Radius Health, Inc. | Conditions: Postmenopausal Osteoporosis | Phase 3 | Status: COMPLETED | Results posted: 2020-12-11